Maestro Surgical

Maestro Surgical, incubated and seed funded by Panacea Venture, is a surgical robotics technology platform launched in 2021. Leveraging a globally patented motion control technology, we aspire to develop an intelligent OR solution that includes high precision, procedure-specific robotic arms with both dexterity and rigidity, and haptic feedback; a synchronized active 3D4K exoscope; and an ergonomic surgeon’s console equipped with a super low latency master-slave system. Our first product under development is a spine surgery robot system that can perform laminectomy and pedicle screw placement. We are the exclusive Chinese startup to win MassRobotics Healthcare Robotics Catalyst Program 2022.